Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
For intracellular staining of hexokinase-1, cells were stained for extracellular markers, fixed in 4% FA at RT, and stained with Anti-Hexokinase 1 (Abcam ab184818) diluted 1:100 in PBS 0.1% Tween-20 at RT
Plasma membrane-bound ER activation appears to be key in AMPK-mediated phosphorylation of ACC in the liver, inactivating the enzyme (20)
If one site becomes irritated, skip it entirely until it heals
Coelho Neto A, Azevedo RP, Santos MBP, Galdieri L de C, DAlmeida V, do AJLG, et al